A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke

Clinical trial NCT06987643 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06987643
Sponsor: EIP Pharma Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Moderate to Severe Acute Ischaemic Stroke Ischaemic Stroke

Start date: 2025-06-20
Primary completion: 2026-09-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.